Microbot Medical(NASDAQ) MBOT

Market Cap$122.24M

Since IPO (2016)-99%

5 Year-75%

1 Year-31%

1 Month-5%

$1.83

+3.39%

+0.06Today

After hours$1.81-$0.02 (-1.09%)

Microbot Medical last closing stock price
Metric	Price	Date
Last close	USD 1.82	2026-08-04

Microbot Medical stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+8.33%	USD 1.68	2026-07-28
1 month	-4.71%	USD 1.91	2026-07-02
3 month	-16.89%	USD 2.19	2026-05-06
Year to date	-9%	USD 2.00	2025-12-31
1 year	-31.32%	USD 2.65	2025-08-04
3 year	-19.47%	USD 2.26	2023-08-04
5 year	-75.34%	USD 7.38	2021-08-05
Since inception	-98.84%	USD 151.95	2016-11-29

Microbot Medical Financials at a Glance

Market Cap

$122.24M

Revenue (TTM)

$105.00K

Net Income (TTM)

-$14.21M

EPS (TTM)

-$0.28

P/E Ratio

-6.58

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$1.83

Volume

3,367

Open

$1.80

Price

$1.83

Volume

3,367

Open

$1.80

Previous Close

$1.82

Daily Range

$1.78 - $1.84

52-Week Range

$1.60 - $4.67

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$1.83

Volume

3,367

Open

$1.80

Previous Close

$1.82

Daily Range

$1.78 - $1.84

52-Week Range

$1.60 - $4.67

Estimated Earnings Date

Aug 11, 2026

MBOT News

These Cold Stocks Are Heating Up

Rich DupreyOct 14, 2010

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Microbot Medical

Microbot Medical develops robotic devices for minimally invasive vascular surgery. Its main product helps doctors guide wires and catheters remotely. This technology aims to make complex procedures safer and easier for both patients and doctors.

Gadgets in the Veins: Products and Services

LIBERTY Endovascular Robotic System: Disposable, remotely operated robot for guiding wires and catheters in blood vessels. (0% of revenue as of 2025)
NovaCross Technology: Devices for opening blocked blood vessels, featuring anchoring and microcatheter integration. (0% of revenue as of 2025)
Self-Cleaning Shunt: Device under development for treating hydrocephalus, a condition causing fluid buildup in the brain. (0% of revenue as of 2025)
Pipeline Portfolio: Multiple future products based on robotic platforms for minimally invasive surgery. (0% of revenue as of 2025)

Growth and Expansion: The Road So Far

Acquired NovaCross technology in 2022 to expand device offerings.
Launched limited market release of LIBERTY system in November 2025.
Collaborated with Emory University and Corewell Health for robotics and telemedicine research in 2024-2025.
Established U.S. sales and distribution infrastructure in 2025.

What Makes Microbot Medical Stand Out

Microbot Medical holds a large patent portfolio and focuses on disposable, mobile robotic systems. Its products aim to reduce hospital costs and improve physician safety. The company partners with major healthcare players to expand its reach and technology base.

Five Things You Need to Know

No revenue reported for 2023-2025; company remains pre-commercial.
Operating loss was $14.7 million in 2025, up 26.7% from 2024.
Raised $86.2 million in 2025 through equity and warrant transactions.
Cash, cash equivalents, and marketable securities totaled $78.6 million at end-2025.
LIBERTY system received FDA clearance in September 2025.

Bottom Line

Microbot Medical is evolving from research to early commercialization, focusing on robotic surgery devices. Its future depends on successful product launches and continued innovation.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Harel Gadot, MBA

Website

microbotmedical.com

Headquarters

Hingham, MA 02043, US

MBOT Financials

Key Financial Metrics (TTM)

Gross Margin

-9.52%

Operating Margin

-15278.10%

Net Income Margin

-13535.24%

Return on Equity

-21.84%

Return on Capital

-18.80%

Return on Assets

-18.21%

Earnings Yield

-15.20%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$122.24M

Shares Outstanding

67.16M

Volume

3.37K

Avg. Volume

1.16M

Financials (TTM)

Gross Profit

-$10.00K

Operating Income

-$16.04M

EBITDA

-$14.17M

Operating Cash Flow

-$15.23M

Capital Expenditure

-$155.00K

Free Cash Flow

-$15.38M

Cash & ST Invst.

$72.50M

Total Debt

$898.00K

Microbot Medical Performance Analysis

Microbot Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Microbot Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

Microbot Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -1.81	14.0%
2023	2023-12-31	USD -1.05	-41.9%
2024	2024-12-31	USD -0.73	-30.5%
2025	2025-12-31	USD -0.29	-60.8%

Microbot Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-1672.1%
Q3	2025-09-30	22.4%
Q4	2025-12-31	30.6%
Q1	2026-03-31	-6.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$105.00K

N/A

Gross Profit

$2.00K

N/A

Gross Margin

1.90%

N/A

Market Cap

$122.24M

N/A

Market Cap/Employee

$2.84M

N/A

Employees

N/A

Net Income

-$3.67M

-41.1%

EBITDA

-$3.66M

-41.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$72.50M

+138.6%

Total Debt

$898.00K

+550.7%

Accounts Receivable

$105.00K

N/A

Inventory

$2.26M

N/A

Long Term Debt

$574.00K

+1095.8%

Short Term Debt

$324.00K

+260.0%

Return on Assets

-18.21%

N/A

Return on Invested Capital

-21.48%

N/A

Free Cash Flow

-$5.16M

-78.8%

Operating Cash Flow

-$5.05M

-75.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VANIVivani Medical, Inc.

VANIVivani Medical, Inc.$1.40+5.26%

RCELAvita Medical Inc.

RCELAvita Medical Inc.$4.63+0.22%

CRDLCardiol Therapeutics Inc.

CRDLCardiol Therapeutics Inc.$1.36+3.82%

ZTEKZentek Ltd.

ZTEKZentek Ltd.$0.67-1.26%

DCGODocGo Inc.

DCGODocGo Inc.$0.65+0.62%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$4.46+1.59%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$0.62+2.93%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

EAElectronic Arts

EAElectronic Arts$209.70-0.00%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$125.33+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.82+0.10%

INTCIntel

INTCIntel$100.86+0.11%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.26-0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.07+0.03%

NVDANvidia

NVDANvidia$211.94+0.03%

Questions About MBOT

What is the current price of Microbot Medical?

Microbot Medical is trading at $1.82 per share.

What is the 52-week range for Microbot Medical?

Over the past 52 weeks, Microbot Medical has traded between $1.60 and $4.67.

How much debt does Microbot Medical have?

As of the most recent reporting period, Microbot Medical reported total debt of $898.00K.

How much cash does Microbot Medical have on hand?

Microbot Medical reported $4.66M in cash and cash equivalents in its most recent financial results.

What is Microbot Medical’s dividend yield?

Microbot Medical does not currently have a dividend yield.

Microbot Medical(NASDAQ) MBOT

Microbot Medical Financials at a Glance

MBOT News

CAPScall of the Week: Neuralstem

5 Things to Watch This Week in the Health-Care Sector

When Giving Up Is a Good Move in Biotech

StemCells Up for All the Right Reasons

These Cold Stocks Are Heating Up

Time to Buy Into Stem Cells?

Is Geron the Perfect Stock?

These Cold Stocks Are Heating Up

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Microbot Medical

Gadgets in the Veins: Products and Services

Growth and Expansion: The Road So Far

What Makes Microbot Medical Stand Out

Five Things You Need to Know

Bottom Line

MBOT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Microbot Medical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MBOT

What is the current price of Microbot Medical?

What is the 52-week range for Microbot Medical?

How much debt does Microbot Medical have?

How much cash does Microbot Medical have on hand?

What is Microbot Medical’s dividend yield?

Premium Investing Services